DDX53 and neoplasm: Here, CT26-tumor bearing mice were treated with RGD-targeted SPIO/PTX-NP (or control NPs) which revealed that RGD-targeting in combination with magnetic targeting strongly reduced the tumor growth and elevated the survival rate.